These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7984656)

  • 1. Alpha 1-adrenoceptors: pharmacological subclassification and therapeutic applications.
    Hieble JP; Ruffolo RR
    Proc West Pharmacol Soc; 1994; 37():163-7. PubMed ID: 7984656
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha 1-adrenoceptors: pharmacological classification and newer therapeutic applications.
    Ruffolo RR; Bondinell W; Ku T; Naselsky DP; Hieble JP
    Proc West Pharmacol Soc; 1995; 38():121-6. PubMed ID: 7480003
    [No Abstract]   [Full Text] [Related]  

  • 3. Subclassification and nomenclature of alpha 1- and alpha 2-adrenoceptors.
    Hieble JP; Ruffolo RR
    Prog Drug Res; 1996; 47():81-130. PubMed ID: 8961765
    [No Abstract]   [Full Text] [Related]  

  • 4. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update.
    Hieble JP; Bylund DB; Clarke DE; Eikenburg DC; Langer SZ; Lefkowitz RJ; Minneman KP; Ruffolo RR
    Pharmacol Rev; 1995 Jun; 47(2):267-70. PubMed ID: 7568329
    [No Abstract]   [Full Text] [Related]  

  • 5. Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1- and beta 2-adrenoceptors.
    Armour JA
    Can J Cardiol; 1997 Mar; 13(3):277-84. PubMed ID: 9117916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic and therapeutic applications of alpha 2-adrenoceptor subtypes.
    Ruffolo RR; Nichols AJ; Stadel JM; Hieble JP
    Annu Rev Pharmacol Toxicol; 1993; 33():243-79. PubMed ID: 8098595
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic use of release-modifying drugs.
    Langer SZ
    Handb Exp Pharmacol; 2008; (184):561-73. PubMed ID: 18064425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 1- and alpha 2-adrenoceptors: pharmacology and clinical implications.
    Starke K; Docherty JR
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S14-23. PubMed ID: 6169956
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological characterization of alpha1-adrenoceptors in equine digital veins.
    Zerpa H; Bailey SR; Berhane Y; Elliott J
    J Vet Pharmacol Ther; 2006 Feb; 29(1):55-61. PubMed ID: 16420303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtypes of alpha1- and alpha2-adrenoceptors mediating noradrenergic modulation of spontaneous inhibitory postsynaptic currents in the hypothalamic paraventricular nucleus.
    Chong W; Li LH; Lee K; Lee MH; Park JB; Ryu PD
    J Neuroendocrinol; 2004 May; 16(5):450-7. PubMed ID: 15117338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alpha 1 adrenergic antagonists].
    ; Hein L
    Pharm Unserer Zeit; 2008; 37(4):290-5. PubMed ID: 18570283
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of alpha-adrenergic reception in bronchial asthma].
    Riabova KG; Grigorian GIu
    Ter Arkh; 1988; 60(10):151-6. PubMed ID: 2906175
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation by yohimbine of alpha-adrenoceptor-mediated vasoconstriction in response to clonidine in the rabbit ear vein.
    Zhao D; Ren LM; Lu HG; Zhang X
    Eur J Pharmacol; 2008 Jul; 589(1-3):201-5. PubMed ID: 18534573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.
    Ruffolo RR; Bondinell W; Hieble JP
    J Med Chem; 1995 Sep; 38(19):3681-716. PubMed ID: 7562902
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.
    Wong WC; Chiu G; Wetzel JM; Marzabadi MR; Nagarathnam D; Wang D; Fang J; Miao SW; Hong X; Forray C; Vaysse PJ; Branchek TA; Gluchowski C; Tang R; Lepor H
    J Med Chem; 1998 Jul; 41(14):2643-50. PubMed ID: 9651170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The medicinal chemistry of alpha 1 blockers].
    Ude C; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2008; 37(4):284-8. PubMed ID: 18618627
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between alpha(1)-adrenergic receptor-induced contraction and extracellular signal-regulated kinase activation in the bovine inferior alveolar artery.
    Hague C; Gonzalez-Cabrera PJ; Jeffries WB; Abel PW
    J Pharmacol Exp Ther; 2002 Oct; 303(1):403-11. PubMed ID: 12235277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the release of serotonin in the dorsal raphe nucleus by alpha1 and alpha2 adrenoceptors.
    Pudovkina OL; Cremers TI; Westerink BH
    Synapse; 2003 Oct; 50(1):77-82. PubMed ID: 12872296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effect of clonidine on mesenteric artery adrenoceptors: agonistic (alpha-2) and antagonistic (alpha-1).
    Silva EG; Feres T; Vianna LM; Okuyama P; Paiva TB
    J Pharmacol Exp Ther; 1996 May; 277(2):872-6. PubMed ID: 8627569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An attempt to characterize alpha-adrenoceptors on human dorsal foot veins in situ.
    Barthel W
    Int J Clin Pharmacol Ther Toxicol; 1993 Jun; 31(6):267-70. PubMed ID: 8101513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.